1 completed, 1 unknown. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Unknown 1 |
Follow CV8102: new trials by email Literature Review of CV8102 trials Research Report on CV8102
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Intratumoral CV8102 in cMEL, cSCC, hnSCC, and ACC CV8102, CV8102 + anti-PD-1 therapy - Melanoma (Skin), Squamous Cell Carcinoma of the Skin | Phase 1 | Unknown | CureVac | 98 | 2017-09-25 | 2021-11-04 |
| Safety and Tolerability of CV8102 Alone and in Combination With a Rabies Virus Vaccine in Healthy Adults CV8102, Rabipur, CV8102 + Rabipur - Rabies | Phase 1 | Completed | CureVac | 72 | 2014-09-01 | 2018-06-06 |
Carcinoma, Adenoid Cystic (1) · Melanoma (1) · Rabies (1) · Squamous Cell Carcinoma of Head and Neck (1)
CureVac (2)
Germany (2) · Austria (1) · France (1) · Russia (1) · Spain (1)
Ingo Meyer, MD (1) · Thomas Eigentler, Prof. Dr. (1)